Novel Harvard Pathology Residency Program May Boost Clinical PGx Testing

A program started last week at Beth Israel Deaconess Medical Center in Boston to study DTC genomic services — the first of its kind in the US — is “a modern extension of our traditional role” as pathologists.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.